期刊文献+

术后血清CYFRA21-1、TK1表达对膀胱尿路上皮癌患者生存预后的关系 被引量:4

Expression of CYFRA21-1,TK1 in patients with bladder urothelial carcinoma after surgery and its relationship with prognosis
暂未订购
导出
摘要 目的探讨术后血清细胞角蛋白19片段(CYFRA21-1)、胸苷激酶1(TK1)表达与膀胱尿路上皮癌(BUC)患者生存预后的关系。方法选取2013年1月~2015年1月屯昌县人民医院85例BUC患者,检测患者术后血清CYFRA21-1、TK1水平,分析不同临床特征患者血清CYFRA21-1、TK1表达的差异,探讨血清CYFRA21-1、TK1表达与BUC患者生存预后的关系。结果经治疗后,BUC患者血清CYFRA21-1、TK1表达量和阳性率比治疗前均明显降低,差异有统计学意义(P<0.05)。不同肿瘤数目、分期、分级和不同预后患者术后血清CYFRA21-1、TK1表达阳性率比较,差异有统计学意义(P<0.05);多发病灶、肿瘤T2-T3分期、高级别和血清CYFRA21-1、TK1阳性表达是影响BUC患者独立危险因素,差异有统计学意义(P<0.05);Log-Rank分析显示,血清CYFRA21-1、TK1阳性表达患者5年生存率显著低于阴性表达患者,差异有统计学意义(P<0.05)。结论术后CYFRA21-1、TK1的表达与BUC患者病情密切相关,可作为预测患者不良预后的独立危险因子。 Objective To investigate the expression of CYFRA21-1,thymidine kinase 1(TK1)in patients with bladder urothelial carcinoma(BUC)after surgery and its relationship with prognosis.Methods 85 patients with BUC were collected for this study.The levels of serum CYFRA21-1 and TK1 were detected.The differences of serum CYFRA21-1 and TK1 expression in patients with different clinical characteristics were analyzed.The relationships between expression of CYFRA21-1,TK1 and the prognosis of BUC patients were investigated.Results After treatment,the levels and positive rates of serum CYFRA21-1 and TK1 in BUC patients were significantly reduced(P<0.05).The positive rates of serum CYFRA21-1 and TK1 were statistically significant in patients with different tumor number,stage,grade and prognosis(P<0.05).Multiple lesions,tumor t2-t3 stage,high grade and positive expression of serum CYFRA21-1 and TK1 were independent risk factors for BUC patients(P<0.05).Log-rank analysis showed that the 5-year survival rate of patients with serum CYFRA21-1 and positive TK1 expression was significantly lower than patients with negative expression(P<0.05).Conclusion The expression of CYFRA21-1 and TK1 is closely related to condition of BUC,which can be used as independent risk factors for predicting poor prognosis of patients.
作者 陈楚君 王宁 王丽娜 沈光辉 Chen Chujun;Wang Ning;Wang Lina(Tunchang People's Hospital,Hainan Tunchang 571600,China)
出处 《中华保健医学杂志》 2021年第4期349-351,共3页 Chinese Journal of Health Care and Medicine
基金 海南省卫生计生行业科研项目(18A200064)。
关键词 膀胱尿路上皮癌 细胞角蛋白19片段 胸苷激酶1 预后 Bladder urothelial carcinoma CYFRA21-1 Thymidine kinase 1 Prognosis
  • 相关文献

参考文献9

二级参考文献73

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1378
  • 2Sauter G, Algaba F, Amin M, et al. Tumour of urinary system: non-invasive urothelial neoplasia[ M ]//In Eble JN, Sauter G, Epstein JI, et al. WHO Classification of Classification of Tumour of urinary system and male genital organs. Lyon: LARCC Press,2004.
  • 3Sobin LH, Gospodariwicz M, Wittekind C. TNM classification of malignant tumours. UICC International Union Against Cancer [ M ]. 7th ed. Wiley-Blackwell,2009 : 262 - 265.
  • 4Sharif H,van Euler H,Westberg S,et al. A sensitive and kineti- cally defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lympho- ma[J]. Vet J,2012,194(1):40-47.
  • 5Chen Y, Ying M, Chen Y, et al. Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1 247 cancer patients in routine clinical settings [ J ]. Int J Clin Oncol, 2010, 15 ( 4 ) : 359 - 368.
  • 6Rademakers SE, Hoogsteen IJ, Rijken PF, et al. Prognostic value of the proliferation marker Ki-67 in laryngeal carcino- ma:Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase Ⅲ randomized trial [ J ]. Head Neck,2013.
  • 7Ioakim-Liossi A, Pantazopoulos D, Karakitsos P, et al. p53 protein expression and proliferative activity in imprints of su- perficial transitional cell carcinoma of the bladder [ J ]. Anal Quant Cytol Histol,2000,22(3) :223 -228.
  • 8Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth fac- tor receptor gene and protein and gefitinib sensitivity in non- small-cell lung cancer [ J ]. J Nat Cancer Inst, 2005,97 (9) : 643 - 655.
  • 9Hong Seok Jang,Ki Mun Kang,Byung Ock Choi,Gyu Young Chai,Soon Chan Hong,Woo Song Ha,Randy L Jirtle.Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma[J].World Journal of Gastroenterology,2008,14(9):1394-1398. 被引量:13
  • 10李扬,林章礼,郑衍平,许瑞明,张敬成,卢小卓.膀胱癌患者手术治疗前后尿液NMP22 UBC BTA CA-199和β_2-MG水平变化分析[J].河北医学,2008,14(12):1400-1403. 被引量:3

共引文献96

同被引文献51

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部